Tocilizumab unfolds colo-protective and immunomodulatory effect in experimentally induced ulcerative colitis via mitigating autophagy and ER stress signaling.
Saved in:
| Title: | Tocilizumab unfolds colo-protective and immunomodulatory effect in experimentally induced ulcerative colitis via mitigating autophagy and ER stress signaling. |
|---|---|
| Authors: | Younes OA; Biologicals Unit at General Administration of Clinical Studies, Egyptian Drug Authority (EDA), Giza, Egypt., Elsherbiny DM; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt., Hanna DMF; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt., Gad AM; Department of Pharmacology, Egyptian Drug Authority (EDA), Formerly NODCAR, Giza, Egypt.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University Kantara Branch, Ismailia, Egypt., Azab SS; Pharmacology and Toxicology Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. samar_saad_azab@pharma.asu.edu.eg. |
| Source: | Inflammopharmacology [Inflammopharmacology] 2024 Dec; Vol. 32 (6), pp. 3881-3898. Date of Electronic Publication: 2024 Aug 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1568-5608 (Electronic) Linking ISSN: 09254692 NLM ISO Abbreviation: Inflammopharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1568-5608 |
|---|---|
| DOI: | 10.1007/s10787-024-01527-7 |